CLINICAL TRIALS PROFILE FOR BREVIBLOC
✉ Email this page to a colleague
All Clinical Trials for BREVIBLOC
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT01114971 ↗ | Labetalol and Esmolol: Vital Signs and Post Operative Pain Management | Completed | Cedars-Sinai Medical Center | Phase 4 | 2009-09-03 | This study proposes to investigate the effects of labetalol or esmolol on managing the vital signs (like blood pressure and heart rate) during surgery, on pain management, and on the later recovery after surgery. It will also assess the cost-effectiveness of Labetalol and esmolol for outpatient surgery. |
| NCT01179113 ↗ | Esmolol Infusion During Laminectomy: Effect on Quality of Recovery | Terminated | Cedars-Sinai Medical Center | Phase 4 | 2011-06-01 | The purpose of this study is to evaluate the effects of esmolol, a drug which is commonly administered during surgery to help control blood pressure and heart rate, on postoperative pain levels and requirements for pain medication. |
| NCT01208402 ↗ | Esmolol for Treatment of Perioperative Tachycardia | Terminated | Baxter Healthcare Corporation | Phase 3 | 2010-09-01 | The purpose of this study is to find out if Esmolol is a safe and effective alternative treatment compared to standard treatment using a long acting beta blocker drug, in controlling abnormal heart rate before, during and immediately after surgery. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for BREVIBLOC
Condition Name
Clinical Trial Locations for BREVIBLOC
Trials by Country
Clinical Trial Progress for BREVIBLOC
Clinical Trial Phase
Clinical Trial Sponsors for BREVIBLOC
Sponsor Name
